<DOC>
	<DOCNO>NCT01728246</DOCNO>
	<brief_summary>The purpose study evaluate efficacy , safety effect Quality Life ( QOL ) tramadol/paracetamol ( APAP ) add-on therapy ( medication take addition another medication ) Filipino participant chronic ( last long time ) osteoarthritis ( disorder , see mostly old person , joint become painful stiff ) .</brief_summary>
	<brief_title>An Efficacy , Safety Effects Quality Life Tramadol/Paracetamol Add-on Therapy Chronic Osteoarthritis</brief_title>
	<detailed_description>This open-label ( people know identity intervention ) , randomize ( study drug assign chance ) , control study evaluate efficacy , safety effect QOL tramadol/APAP add-on therapy Filipino participant suffer chronic pain chronic osteoarthritis . Participants randomly assign 2 group : tramadol/APAP group non tramadol/APAP group . Participants tramadol/APAP group receive celecoxib 200 milligram ( mg ) fix dose combination tramadol ( 37.5 mg ) /APAP ( 325 mg ) add therapy , participant non-tramadol/APAP group receive celecoxib 200 mg . The total duration study 4 week . The participant group give celecoxib 200 mg daily 4 week . In addition , participant tramadol/APAP group give add-on tramadol/APAP dose 3 time day 4 week . Participants ask return follow-up Weeks 2 4 . Efficacy assess use 100 millimeter ( mm ) Visual Analog Scale ( VAS ) QOL assess use Oswestry Disability Index ( ODI ) . Participant safety monitor throughout study .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Diagnosed chronic osteoarthritis knee hip great ( &gt; ) equal ( = ) 1 year ( base American College Rheumatology ( ACR ) diagnostic criterion osteoarthritis ) , experience least moderate osteoarthritis pain ( &gt; =50 millimeter [ mm ] 100 mm Visual Analog Scale [ VAS ] ) On Cyclooxygenase 2 ( COX2 ) inhibitor least 2 week precede study Women childbearing potential must negative pregnancy test Women child bear potential must agree use accept method contraception Participant sign write informed consent form Participants take Monoamine oxydase ( MAO ) inhibitor , neuroleptic drug seizure Severe hepatic impairment ( impaired ability liver fulfill role metabolism ) On maintenance tramadol and/or paracetamol ( APAP ) On sedative hypnotic , shortacting analgesic , topical medication anesthetic , and/or muscle relaxant Pregnant , lactate breastfeeding participant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Celecoxib</keyword>
	<keyword>Tramadol</keyword>
	<keyword>Paracetamol</keyword>
</DOC>